Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Weight loss varies by indication and dose, with approximately 15-21% reduction at higher doses in obesity trials and typically lower percentages in type 2 diabetes studies
"It's been absolutely great." Madison surpassed her 50-pound target goal, and as of now she has lost 60 pounds since the start of her journey
NAD+ Studied for cellular energy and metabolic support
Retatrutide exhibits highest potency at the GIP receptor (8.9-fold greater than endogenous GIP), with moderate activation of the GLP-1 receptor (0.4-fold) and lower, yet functional, glucagon receptor activity (0.3-fold)
US$ 23.43
US$ 27.71
US$ 25.00
US$ 22.79
US$ 22.88
US$ 23.27
